Global Clinical Chemistry Analyzers Market was valued at USD 12,123 Million in 2021, is expected to grow at a CAGR of 4.8% over the forecast period (2022

PUNE, India, March 15, 2022 /PRNewswire/ — Chemical analyzers are medical laboratory devices used to measure the concentration of particular compounds in samples of serum, plasma, urine and other bodily fluids. Substances tested by this equipment include specific metabolites, electrolytes, proteins and drugs. In today’s healthcare environment, laboratories around the world are under pressure to improve patient care while reducing operating costs. It is one of the most essential aspects of clinical laboratory analysis, and the market for clinical chemistry analyzers has made significant progress in recent years. A wide range of tests, including diabetes, liver and kidney function and electrolyte tests, as well as lipid profiles, thyroid tests, antibiotic level monitoring and other drug level monitoring tests , can now be performed in the doctor’s laboratory using an efficient, state-of-the-art chemistry analyzer. The leading manufacturers in the market are focused on providing a wide range of features such as interactive touch screen interface, advanced optics, integrated curve fitting software, bichromatic and monochromatic playback, IAD filters long lasting, and much more. Over the past few decades, the clinical chemistry instrumentation industry has seen a rapid evolution of technological improvements. New features, such as closed-tube sampling, automated maintenance processes, simplified calibration, and web-based remote diagnostics have been introduced with each new system generation. These aim to help laboratories better meet the needs of physicians and patients while creating efficiencies, improving quality, reducing costs and addressing workforce fluctuations. . Thus, these factors are driving the growth of global clinical chemistry analyzer market.

Read our 420+ page Medical Commode Market report published by Absolute Markets Insights

By type

Automated clinical chemistry analyzers are growing in popularity because automating clinical chemistry results in higher test volume and shorter turnaround time. When managed by laboratory specialists, the use of automated analyzers that can combine a variety of assays, assay types, reagents, software, and peripherals provides a holistic package to improve efficiency and clinical results. Additionally, automated analyzers improve user safety against biohazards and reduce the possibility of cross-contamination with increased throughput. The major players in the market are focusing on the integration of advanced technologies in the analyzers. For example, MNCHIP Technologies Co., Ltd. offers an automated clinical chemistry analyzer with various built-in features such as a multi-test panel, enhanced visual experience with touch screen, simplified user interface and also equipped with a printer handset to print reports instantly. Thus, with such advancements and automation, the clinical chemistry analyzer market is booming globally.

Get a sample PDF report with related charts and graphs (pre and post COVID-19 impact analysis):

Per end user

In recent years, there has been an increase in health care awareness among a large population, which has led to an increase in clinical testing. Molecular function tests are growing in popularity because these tests measure blood sugar, electrolytes, fluid balance and kidney function, which are vital for the early detection of chronic diseases. Moreover, the growing concerns about heart diseases have also led to an increased demand as these heart tests measure specific biological markers (biomarkers) in the blood to detect various heart diseases. Clinical Chemistry Analyzers provide high-throughput point-of-care solutions for diagnosing myocardial infarction and other cardiac diseases by measuring levels of STAT, cardiac troponin, CKM and CKB, myoglobin. Thus, with the above mentioned factors, the demand for the clinical chemistry analyzer market is growing globally.

Speak to our analyst if you have any questions before purchasing this report:

By region

Asia Pacific is expected to be the fastest growing region in the clinical chemistry analyzer market for the forecast period. The geriatric population in countries like China, Japan and India is increasing rapidly, which has led to an increase in various age-related diseases such as hypertension, kidney problems, diabetes, liver problems and others. As these health issues require different tests like basic metabolic panel, lipid profiles to be performed, hence the demand for clinical chemistry analyzers is increasing in Asia Pacific.

Request customization to meet your specific research needs:

Global Scope of Clinical Chemistry Analyzer Market Research:

base year


Historical years

2015 – 2020

Forecast years

2022 – 2030

Segments Covered

By measurement technologies, type, substances, photometric rate, sample load capacity, application, end user

Quantitative units

Revenue in USD Million/Billion (2015 – 2030) and CAGR from 2022 – 2030

Regions covered

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa

Countries covered

United States, Canada, Mexico, Rest of North America, France, United Kingdom, Spain, Germany, Italy, Nordic countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, United Arab Emirates, Egypt, Kuwait, South Africa, Rest of Middle East and Africa, Brazil, Argentina, Rest of Latin America

Profiled companies

Abbott, Beckman Coulter, Inc., Cardinal Health, F. Hoffmann-La Roche Ltd., Hitachi High-Tech Corporation, HORIBA Medical, MNCHIP Technologies Co., Ltd., Siemens Healthcare GmbH, Randox Laboratories Ltd., Trivitron Healthcare, Thermo Fisher Scientific Inc among others.

Report cover

Market determinants and influencing factors, macro and micro economic indicators, market dynamics (drivers, restraints, opportunities, challenges), trends, exclusive details on the effect of the pandemic, Porter’s five forces analysis, Competitor Profiles and Landscape, Company Market Share Analysis, Product Benchmark

Scope of customization

We provide the ability to customize region-specific reports that will cover exclusive information about the regions and their respective countries.

Additional modules

We offer our report in different languages, including German, French, Spanish, Japanese and Korean.

Check out our exclusive press releases at Global Industry News24

Global clinical chemistry analyzer market:

  • By Measurement Technologies
    • Photometric and colorimetric tests
    • Ion selective potentiometer
    • Latex clumping
    • Others
  • By type
    • Automatique
    • Benchtop analyzer
    • Other
  • By substances
    • Serum
    • Plasma
    • Urine
    • Other bodily fluids
  • By photometric flow
    • 400/800 with ISE
    • 800/1200 with ISE
    • Up to 8,000 tests/hour
    • Up to 9,800 tests/hour with dual ISE
    • Others
  • Per sample load capacity
    • 80 (8 racks x 10 samples), 22 samples per carousel
    • 150 (15 racks x 10 samples), 22 samples per carousel
    • 400 samples (set of 2 x 20 racks)
    • Others
  • By request
    • Diabetes
    • Testing metabolic functions or cardiac markers
    • Drug testing
    • Other
  • Per end user
    • doctor’s office laboratory
    • Hospital laboratory
    • Point-of-care clinics
    • University and research institutes, veterinary laboratories and agri-food laboratories
    • Central laboratory
    • Reference laboratory
    • Integrated delivery network
    • Others

Buy Latest Detailed Clinical Chemistry Analyzer Market Report @

Main categories of related health care:

  • Point-of-Care (PoC) Lipid Testing MarketIn terms of revenue, the Point-of-Care (PoC) Lipid Testing market has been valued at US$260.48 million in 2021 with a CAGR of 4.34% over the forecast period (2022 – 2030).
  • pregnancy test marketIn terms of revenue, the global pregnancy test market was valued at US$1444.68 million in 2019 and is expected to grow at a CAGR of 13.17% over the forecast period.
  • Automated and Rapid Microbiological Testing MarketIn terms of revenue, the global pregnancy test market is expected to grow at a CAGR of 22.12% during the forecast period.
  • Molecular diagnostics marketThe global molecular diagnostics market is expected to grow at a CAGR of 8.1% by 2029 driven by the growing demand for precision medicine applications and COVID-19 applications.
  • STD Diagnostics MarketIn terms of revenue, the global STD diagnostics market has been valued at US$88,706.7 million in 2018 and is expected to grow at a CAGR of 5.06% over the forecast period.
  • Canine Lymphoma Treatment MarketThe global canine lymphoma treatment market is expected to grow at a CAGR of 8% during the forecast period (2020-2028).

Browse Absolute Markets Insights’ plethora of reports on Health care Category

About Us:

Absolute Markets Insights helps to provide accurate and recent trends related to consumer demand, consumer behavior, sales and growth opportunities, for a better understanding of the market, thus aiding in design, presentation and forecasting product demands. Our experts provide you with the end products that can deliver transparency, actionable data, a cross-channel deployment program, performance, accurate testing capabilities, and the ability to drive continuous optimization.

From in-depth analysis and segregation, we serve our clients to meet their immediate and ongoing research needs. Careful analysis has an impact on important decisions and hence the source of Business Intelligence (BI) plays an important role, which allows us to stay informed about current and upcoming market scenarios.

Contact us:

Contact Name: Shreyas Tanna
Company: Absolute overview of the markets
Email ID: [email protected]
Call: IN +91-7400-24-24-24, USA +1-510-420-1213

SOURCE Absolute Markets Insights

Comments are closed.